Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone palmitate relapse-prevention study in schizoaffective disorder
2009-017271-17Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizoaffective disorder comparing Paliperidone palmitate with Placebo (2 arms). Primary endpoint: Time to relapse. Started Jul 2010; status: completed.
02
Drugs
paliperidone palmitate
03
Conditions
schizoaffective disorder
Beyond the preview
Go deeper on 2009-017271-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017271-17.